Harrison.ai accelerates expansion of operations into the USA
Health technology company and developer of AI-powered medical diagnostic support and workflow solutions Harrison.ai has accelerated expansion of its operations into the USA, a move supported by $112 million of series C funding. The funding will also fuel the company’s product roadmap and continued growth in the UK, EMEA and APAC.
Harrison.ai’s technology in radiology and pathology assists clinicians with identifying signs of cancer and other critical illnesses earlier, improving treatment decisions and patient outcomes. It uses AI to analyse CT scans, x-rays and pathology slides, supporting clinicians in detecting and diagnosing medical conditions faster and more accurately.
“The growing demand for equitable and effective healthcare calls for advanced systems like AI to enhance human diagnostics and address disparities in access to care,” said co-founder and CEO Dr Aengus Tran. “Harrison.ai meets this need by developing clinical-grade AI models designed to improve capacity.”
Picture: Harrison.ai’s technology uses AI to analyse CT scans.
Read this report on page 26 of the June 2025 issue of RAD Magazine.
